link to page 2 
 
 
Updated April 27, 2017
Infectious Diseases Outbreaks: Yellow Fever in Central Africa 
Introduction  
victims often develop fever, nausea, muscle pain, and 
Since 1980, emerging infectious diseases (EID) have 
vomiting. In most instances, related symptoms resolve 
resulted in more frequent outbreaks that are causing higher 
within four days. According to the CDC, roughly 15% of 
numbers of human infections. EID are either new diseases 
those who contract yellow fever develop severe symptoms, 
or existing ones that have emerged in new areas. In recent 
including organ failure. The “yellow” in the name of the 
decades, 
new EID have included Severe Acute Respiratory 
disease refers to the jaundice—yellowing of the skin and 
Syndrome (SARS) and HIV/AIDS. EID that have spread to 
whites of the eyes, often indicating liver damage—that 
new geographical areas have included yellow fever and 
typically occurs among severe cases. About half of those 
Zika. Zoonotic pathogens (organisms that spread from 
who experience severe yellow fever die within 10 days. 
animals to humans, often through a vector like a mosquito) 
While specific treatment for the virus does not exist, yellow 
sicken some 1 billion people annually, roughly 15 million 
fever can be prevented through vaccination. Eradication is 
of whom die. Notable EID outbreaks caused by zoonotic 
not considered feasible, as the disease is also found in 
pathogens include SARS (2003), Avian Influenza H5N1 
primates, from which mosquitos can transmit the disease to 
(2005), Pandemic Influenza H1N1 (2009), Middle East 
humans. 
Respiratory Syndrome coronavirus (MERS-CoV, 2013), 
West Africa Ebola (2014), Zika (2015), and Central Africa 
Yellow Fever Outbreak in Central Africa 
Yellow Fever (2016) and South America Yellow Fever 
Insufficient laboratory capacity in many of the areas where 
(2016-2017).  
the disease is endemic and parallel symptoms caused by 
other common tropical diseases (e.g., malaria, dengue, and 
On average, Congress has provided about $130 million 
other hemorrhagic fevers) have limited the ability to 
annually through regular appropriations to the U.S. Agency 
estimate the annual cases and deaths. A modelling study 
for International Development (USAID) and the U.S. 
conducted in 2013 estimated that 84,000-170,000 cases 
Centers for Disease Control and Prevention (CDC) for 
occurred in Africa during that year, including 29,000-
global pandemic preparedness efforts. Emergency 
60,000 deaths. 
responses to EID outbreaks have varied, however, but tend 
to follow introduction of the disease into the United States. 
Angolan health officials reported a yellow fever outbreak to 
For example, the 114th Congress appropriated roughly $5 
the World Health Organization (WHO) in January 2016. 
billion and $2 billion to help control the West Africa Ebola 
Yellow fever is endemic in Angola, but this was the first 
and Zika outbreaks, respectively, but other Congresses did 
large-scale outbreak in 28 years. The last outbreak in the 
not provide funds to address SARS or yellow fever 
country occurred in 1988, with 37 cases and 14 deaths. 
outbreaks. Due to the unpredictable nature of EID 
Laboratory tests confirmed yellow fever among 884 of 
outbreaks, some question whether Congress will continue to 
4,347 samples collected between December 5, 2015, and 
emphasize infectious diseases that reach the U.S. shores or 
October 20, 2016. Laboratory tests also indicated that 121 
whether the 115th Congress might develop a more proactive 
of 377 suspected deaths were caused by yellow fever. 
approach. 
The disease has spread from Angola to several countries, 
In January 2016, a yellow fever outbreak in Central Africa 
including Brazil, China, the Democratic Republic of Congo 
emerged in an urban area for the first time. It overwhelmed 
(DRC), and Kenya. The imported yellow fever cases in 
the capacity of the affected countries and subsequently 
China and Kenya (11 and 2 cases, respectively) were 
caused an unprecedented number of illnesses and deaths. 
quickly detected and did not spread further. In Brazil and 
EID outbreaks are revealing not only the threat that weak 
the DRC, however, imported cases led to additional 
health systems in developing countries pose to the world, 
infections. Scientists are working to control the yellow 
but also are elucidating gaps in international frameworks 
fever outbreak in Brazil and have contained it in the DRC. 
for responding to global health crises. The central Africa 
Laboratory tests were conducted on 2,800 samples and 
yellow fever outbreak raises questions about what role the 
indicated that 78 yellow fever cases, including 16 deaths, 
United States might play in addressing infectious disease 
had occurred in the DRC from January 1 through October 
outbreaks that are occurring at greater frequency and are 
26, 2016. WHO reported that 57 of the cases in the DRC 
threatening U.S. health security. 
were related to the Angola outbreak. 
Background on Yellow Fever 
International Response 
Yellow fever is a disease transmitted by mosquitoes 
The unprecedented size of the central African yellow fever 
endemic in 47 countries across sub-Saharan Africa (SSA) 
outbreak has raised concern among the international 
and South America (see
 Figure 1). Roughly 90% of annual 
community about the pace at which EID outbreaks are 
yellow fever cases occur in SSA. Many who contract the 
occurring and overrunning global response structures. 
virus do not exhibit symptoms. Among symptomatic cases, 
WHO Director-General Margaret Chan convened an 
https://crsreports.congress.gov 

Infectious Diseases Outbreaks: Yellow Fever in Central Africa 
Emergency Committee meeting in May 2016 to discuss the 
Outlook 
yellow fever outbreak. She was particularly concerned 
The accelerated pace at which EID outbreaks are occurring 
about the urban spread of the disease (a first for Angola) 
has overwhelmed international health networks and is 
and the risk of further spread across the region and the 
raising questions about how the United States and other 
world. The committee concluded that the outbreak did not 
countries can address this challenge. The mass vaccination 
“constitute a Public Health Emergency of International 
campaign to stop the central African yellow fever outbreak 
Concern but is a serious public health event which warrants 
became the largest such effort in recent history, and trends 
intensified national action with international support.” 
indicate that other EID might require similar unprecedented 
responses. Issues raised by the outbreak include the 
Infectious disease outbreaks in urban areas are a growing 
following:  
problem that is overwhelming long-standing international 
  
Global Risks—Is the global risk of future yellow fever 
stopgap measures. For example, the WHO and several 
outbreaks increasing? WHO warns that the global risk 
international organizations created the International 
of future yellow fever outbreaks is heightened by 
Coordination Group on the Provision of Vaccines in 1997 
climate change, increased international trade and travel, 
to manage the production and distribution of vaccine 
and the resurgence of the 
Aedes aegypti mosquito 
stockpiles for cholera, meningitis, and yellow fever. The 
(which can spread other tropical diseases, including 
stockpile was created to avert the spread of deadly 
chikungunya, dengue, and Zika).  
infectious disease outbreaks from countries without 
  
International Preparedness—Is the international 
sufficient capacity to control them. In recent years, 
community prepared to control additional EID 
however, mosquito-borne outbreaks, including yellow 
outbreaks? Many poor countries lack the ability to 
fever, have taxed the global vaccine stockpile, even 
detect, prevent, and contain infectious disease outbreaks, 
depleting it twice in 2016. A Brazilian manufacturer (Bio-
potentially exacerbating the reach of such outbreaks. 
Manguinhos) sent additional yellow fever vaccine doses to 
Escalating urbanization further complicates efforts to 
supplement the depleted stockpiles. 
control infectious disease threats, as curbing disease 
outbreaks in dense, urban areas is time- and resource-
Yellow fever vaccine shortages forced WHO to employ a 
intensive. For example, more than 41,000 volunteers 
fractional dosing campaign, which used one-fifth of the 
and 8,000 vaccination teams were enrolled to vaccinate 
standard yellow fever vaccine dose. Experts hoped that 
some 30 million people against yellow fever in Angola, 
fractional dosing would provide sufficient protection to stop 
the DRC, and Uganda.  
the spread of the diseases and last for at least one year. The 
strategy effectively controlled the outbreak, with Angola 
  
Congressional Response—What approach might the 
and the DRC having declared the outbreak over in 
115th Congress consider going forward? Some groups 
December 2016 and February 2017, respectively. Experts 
advocate for deepening investments in global health 
caution, however, that the region remains vulnerable to 
system strengthening efforts worldwide, arguing that 
future outbreaks because the disease is endemic to the area. 
emergency responses require considerably more 
WHO warns that detection of future outbreaks may be 
resources than preventive measures and that ignoring 
delayed by persistent deficiencies in disease surveillance 
poor health conditions worldwide imperils global and 
and laboratory capacities in both countries.  
domestic security. Others express concern about how 
broad-based health systems support could be adequately 
measured and monitored.  
Figure 1. Areas at Risk of Yellow Fever Transmission: Sub-Saharan Africa and South America 
 
Source: Adapted by CRS from CDC webpage on Yellow Fever at https://www.cdc.gov/yellowfever/, accessed on January 27, 2017. 
Notes: Data for sub-Saharan Africa and Latin America were developed in July 2015 and March 2014, respectively. 
 
IF10603
Tiaji Salaam-Blyther, Specialist in Global Health    
https://crsreports.congress.gov 
Infectious Diseases Outbreaks: Yellow Fever in Central Africa 
 
 
 
Disclaimer This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff to 
congressional committees and Members of Congress. It operates solely at the behest of and under the direction of Congress. 
Information in a CRS Report should not be relied upon for purposes other than public understanding of information that has 
been provided by CRS to Members of Congress in connection with CRS’s institutional role. CRS Reports, as a work of the 
United States Government, are not subject to copyright protection in the United States. Any CRS Report may be 
reproduced and distributed in its entirety without permission from CRS. However, as a CRS Report may include 
copyrighted images or material from a third party, you may need to obtain the permission of the copyright holder if you 
wish to copy or otherwise use copyrighted material. 
 
https://crsreports.congress.gov | IF10603 · VERSION 6 · UPDATED